Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2012
04/03/2012US8146586 Liquid ejection cartridge and liquid ejection device
04/03/2012DE202007019288U1 System für Fluidreinigung System for fluid purification
04/03/2012CA2756674C Microemulsion & sub-micron emulsion process & compositions
04/03/2012CA2707882C Chewable softgel capsules
04/03/2012CA2648945C Chemoprotective methods and compositions
04/03/2012CA2569683C Oral antimicrobial pharmaceutical compositions
04/03/2012CA2549018C Consumer customized dosage forms
04/03/2012CA2537041C Modified release compositions comprising tacrolimus
04/03/2012CA2508692C Combination medicament
04/03/2012CA2508015C Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
04/03/2012CA2494569C An analgesic agent for newborn or fetal subjects
04/03/2012CA2487789C Composition for improving melasma and composition for reducing skin dullness
04/03/2012CA2467759C Use of nanoparticles as carriers for biocides in ophthalmic compositions
04/03/2012CA2459309C Sustained release of microcrystalline peptide suspensions
04/03/2012CA2434930C Treating pulmonary disorders with gaseous agent causing repletion of gsno
04/03/2012CA2294981C Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
04/03/2012CA2294031E Self-emulsifying formulation for lipophilic compounds
03/2012
03/29/2012WO2012040710A2 Stabilized nanobubbles for diagnostic and therapeutic applications
03/29/2012WO2012040651A2 Controlled release formulations of opioids
03/29/2012WO2012040623A2 Nanostructured gels capable of controlled release of encapsulated agents
03/29/2012WO2012040595A2 Administration of serine protease inhibitors to the stomach
03/29/2012WO2012040331A2 Multistage nanoparticles
03/29/2012WO2012040262A1 Method and system for forming a pharmaceutical product directly onto a packaging surface
03/29/2012WO2012040229A1 Corticosteroid particles and method of production
03/29/2012WO2012040224A2 Oral composition and method of forming and using same
03/29/2012WO2012040082A2 Antidiabetic solid pharmaceutical compositions
03/29/2012WO2012039979A2 Rapid diffusion of large polymeric nanoparticles in the mammalian brain
03/29/2012WO2012039790A1 Manufacture of tablets from energy-applied powder blend
03/29/2012WO2012039789A1 Manufacture of variable density dosage forms utilizing radiofrequency energy
03/29/2012WO2012039788A1 Multi-layered orally disintegrating tablet and the manufacture thereof
03/29/2012WO2012039768A2 Itraconazole formulations
03/29/2012WO2012039691A2 Synergic effect
03/29/2012WO2012039642A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
03/29/2012WO2012039641A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
03/29/2012WO2012039596A2 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
03/29/2012WO2012039525A1 Material and method for enabling the absorption of carbon dioxide into skin mucosa for providing a v-shaped jaw line and reducing the size of the face by breaking down excessive facial fat and proteins
03/29/2012WO2012038898A1 Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease
03/29/2012WO2012038801A1 A spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles
03/29/2012WO2012038371A1 Caspofungin composition
03/29/2012WO2012038333A2 Composition to act in prevention and to take care of diabetic foot
03/29/2012WO2012037834A1 5α-ANDROSTANE (ALKYL)-3β,5,6β-TRIOL INJECTION AND PREPARATION METHOD THEREFOR
03/29/2012WO2012037667A1 Synthesis of fluorescent noble metal nanoparticles
03/29/2012WO2012037665A1 Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
03/29/2012WO2012037648A1 Process for chelating copper ions using cb-te2a bifunctional chelate
03/29/2012WO2012013756A3 Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol
03/29/2012WO2012001411A3 Pharmaceutical compositions for sublingual delivery of opioids
03/29/2012WO2011161666A3 Enclosed liquid capsules
03/29/2012WO2011150181A3 Compositions and methods for treating or inhibiting infection by francisella tularensis
03/29/2012WO2011150175A3 Compositions and methods for pain reduction
03/29/2012WO2011146030A3 Effervescent antihistamine formulations
03/29/2012WO2011143128A3 Multi-phasic nanostructures for imaging and therapy
03/29/2012WO2011140519A3 In vivo gelling pharmaceutical pre-formulation
03/29/2012WO2011112070A3 A composition to boost and enhance immune system and method of preparing thereof
03/29/2012WO2011109341A3 Oil composition containing carvone for use on aquatic creatures and amphibians
03/29/2012WO2011107855A3 Sustained release oral liquid suspension dosage form
03/29/2012WO2011101868A3 Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
03/29/2012WO2011098552A3 Methods and compositions for the preparation of aerosols
03/29/2012WO2011084593A3 Abuse-resistant formulations
03/29/2012WO2011080148A3 An aqueous intravenous nanosuspension with reduced adverse effects
03/29/2012WO2011063990A3 Spider silk particles for controlled and sustained delivery of compounds
03/29/2012WO2010149196A8 Taste masked dosage form of pharmaceutically acceptable salt of escitalopram
03/29/2012US20120077766 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
03/29/2012US20120077764 Compositions and method for treating infection in cattle and swine
03/29/2012US20120077740 Methods for making Apo-2 Ligand using divalent metal ions
03/29/2012US20120077270 Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
03/29/2012US20120076921 Method and system for forming a pharmaceutical product directly onto a packaging surface
03/29/2012US20120076866 Particulate pharmaceutical composition
03/29/2012US20120076865 Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
03/29/2012US20120076863 Nanoparticulate stabilized anti-hypertensive compositions
03/29/2012US20120076862 Methods of enhancing drug delivery and effectiveness of therapeutic agents
03/29/2012US20120076861 Materials and methods for the treatment of celiac disease
03/29/2012US20120076860 Compositions, methods, and systems relating to controlled crystallization and/or nucleation of molecular species
03/29/2012US20120076859 Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases
03/29/2012US20120076858 Orally Disintegrating Dosage Forms Containing Taste-Masked Active Ingredients
03/29/2012US20120076857 Forms of rifaximin and uses thereof
03/29/2012US20120076856 Orodispersible pharmaceutical composition of perindopril
03/29/2012US20120076855 Oral testosterone composition
03/29/2012US20120076854 Cellular compositions for use in therapy
03/29/2012US20120076853 Composition for use in gene therapy
03/29/2012US20120076852 Drug carrier and drug carrier kit for inhibiting fibrosis
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076850 Topical Patch For Pain Relief Using Cooling Agent
03/29/2012US20120076849 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
03/29/2012US20120076848 Method and system for effecting changes in pigmented tissue
03/29/2012US20120076847 Medical instrument and method of manufacturing the same
03/29/2012US20120076845 Saline nose wipe and methods of manufacture and use
03/29/2012US20120076841 Porous Particles Loaded with Cosmetically or Pharmaceutically Active Compounds
03/29/2012US20120076839 Antiperspirant compositions
03/29/2012US20120076838 Poorly soluble drug containing microsphere with improved bioavailabilty and method of preparing the same
03/29/2012US20120076837 Surface engineering of tissue graft materials for enhanced porosity and cell adhesion
03/29/2012US20120076836 Polyion complex of double-stranded ribonucleic acid
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076834 Protective Coatings For Acidic Active Ingredients
03/29/2012US20120076833 Surface-oriented antibody coating for the reduction of post-stent restenosis
03/29/2012US20120076832 Synthesis and use of therapeutic metal ion containing polymeric particles
03/29/2012US20120076831 Compositions and methods for induction of antigen-specific tolerance
03/29/2012US20120076830 Differentiation of stem cells with nanoparticles
03/29/2012US20120076784 Highly concentrated, liquid formulations of anti-egfr antibodies
03/29/2012US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
03/29/2012US20120076738 Combination treatment for dermatological conditions
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 2991